by GlobeNewsWire | Jun 8, 2016 | Globe Newswire
BURNABY, British Columbia, June 08, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, announced that Dr. Simon Pimstone, Xenon’s President and Chief Executive Officer, will present today at the...
by GlobeNewsWire | Jun 7, 2016 | Globe Newswire
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 07, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of...
by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
NEW YORK, June 01, 2016 (GLOBE NEWSWIRE) — According to Tyme Technologies, Inc. (OTCQB:TYMI), a clinical-stage pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications, conclusions...
by GlobeNewsWire | May 24, 2016 | Globe Newswire
BRANFORD, Conn., May 24, 2016 (GLOBE NEWSWIRE) — BioXcel Corporation, a global leader in real-time big data platforms for the discovery and development of transformative patient treatments, today announced the initiation of a strategic collaboration with Alnylam...
by GlobeNewsWire | May 18, 2016 | Globe Newswire
– Data to be Presented at the 2016 ASCO Annual Meeting – – Company to Discuss Results with Regulators after Additional Follow Up – BOSTON, May 18, 2016 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that interim results from the...